Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort
de Ruiter, L. R. J., Loonstra, F. C., Jelgerhuis, J. R., Coerver, E. M. E., Toorop, A. A., van Leeuwen, I. C. E., Noteboom, S., Moraal, B., Strijbis, E. M. M., Schoonheim, M. M. & Uitdehaag, B. M. J., 1 Mar 2023, In: Multiple Sclerosis and Related Disorders. 71, 104568.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Toorop, A. A., van Kempen, Z. L. E., Steenhuis, M., Nielsen, J., Sinnige, L. G. F., van Dijk, G., Roosendaal, C. M., Arnoldus, E. P. J., Hoitsma, E., Lissenberg-Witte, B. I., de Jong, B. A., Oosten, B. W. V., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T. & Killestein, J., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 482-486 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access4 Citations (Scopus) -
Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis
Toorop, A. A., Hogenboom, L., Bloem, K., Kocyigit, M., Commandeur, N. W. M., Wijnants, A., Lissenberg-Witte, B. I., Strijbis, E. M. M., Uitdehaag, B. M. J., Rispens, T., Killestein, J. & van Kempen, Z. L. E., 1 Jun 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 6, p. 487-493 7 p., jnnp-2022-330793.Research output: Contribution to journal › Article › Academic › peer-review
1 Citation (Scopus) -
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis
the T2B! immunity against SARS-CoV-2 study group & T2B! immunity against SARS-CoV-2 study group, Jan 2023, In: Annals of neurology. 93, 1, p. 103-108 6 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus) -
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 others, 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.Research output: Contribution to journal › Article › Academic
2 Citations (Scopus)